Featured Post

Latest Gold News

This analyst sees nothing to stop gold from continuing climb Cyber Terrorism another reason to own gold says Faber Fed doves supportin...

Friday, December 16, 2011

BioSante (BPAX) Downgraded by Numerous Analysts

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) was downgraded by a variety of analysts.

BioSante Pharmaceuticals, Inc. (BPAX) was downgraded by McNicoll Lewis & Vlak to a “Hold” rating.

BioSante Pharmaceuticals, Inc. was downgraded by MLV & Co from a “Buy” rating to a “Hold” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Roth Capital from a “Buy” rating to a “Neutral” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Rodman & Renshaw from an “Outperform” rating to a “Market Perform” rating.

BioSante Pharmaceuticals, Inc. was downgraded by JMP Securities from an “Outperform” rating to a “Market Perform” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Jefferies (NYSE:JEF) from a “Buy” rating to a “Hold” rating.

BioSante Pharmaceuticals, Inc. was downgraded by Leerink from an “Outperform” rating to a “Market Perform” rating.

No comments: